1-6 of 6
J Schlom
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.

Free
C Russoniello, C Somasundaram, J Schlom, Y M Deo, T Keler
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (9): 2237–2243.
Published: 01 September 1998
View articletitled, Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.
Open the PDF for Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells. in another window
Journal Articles

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.

Free
S F Slovin, H I Scher, C R Divgi, V Reuter, G Sgouros, M Moore, K Weingard, R Pettengall, M Imbriaco, A El-Shirbiny, R Finn, J Bronstein, C Brett, D Milenic, A Dnistrian, L Shapiro, J Schlom, S M Larson
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (3): 643–651.
Published: 01 March 1998
View articletitled, Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
Open the PDF for Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer. in another window
Journal Articles

Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.

Free
K Y Tsang, M Zhu, C A Nieroda, P Correale, S Zaremba, J M Hamilton, D Cole, C Lam, J Schlom
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (12): 2439–2449.
Published: 01 December 1997
View articletitled, Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.
Open the PDF for Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. in another window
Journal Articles

Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.

Free
D J Macey, E J Grant, L Kasi, M G Rosenblum, H Z Zhang, R L Katz, P T Rieger, D LeBherz, M South, J W Greiner, J Schlom, D A Podoloff, J L Murray
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (9): 1547–1555.
Published: 01 September 1997
View articletitled, Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
Open the PDF for Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial. in another window
Journal Articles

Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.

Free
R F Meredith, M B Khazaeli, W E Plott, W E Grizzle, T Liu, J Schlom, C D Russell, R H Wheeler, A F LoBuglio
Journal: Clinical Cancer Research
Clin Cancer Res (1996) 2 (11): 1811–1818.
Published: 01 November 1996
View articletitled, Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.
Open the PDF for Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer. in another window
Journal Articles

Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.

Free
T Mulligan, J A Carrasquillo, Y Chung, D E Milenic, J Schlom, I Feuerstein, C Paik, P Perentesis, J Reynolds, G Curt
Journal: Clinical Cancer Research
Clin Cancer Res (1995) 1 (12): 1447–1454.
Published: 01 December 1995
View articletitled, Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.
Open the PDF for Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma. in another window